Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | LTA4H | P09960 | 1/20 | 0.62 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.59 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 5/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.55 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.53 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | PPARG | P37231 | 6/20 | 0.50 |
| ▸ | PPARD | Q03181 | 6/20 | 0.50 |
| ▸ | PPARA | Q07869 | 6/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.50 |
| ▸ | TLR2 | O60603 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | FABP4 | P15090 | 2/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3809162 | 1.00 | CYP1A2 (0.67) | CYP1A2LTA4HFFAR4FFAR1TSHR | |
| SCHEMBL798792 | 1.00 | CYP1A2 (0.67) | CYP1A2LTA4HFFAR4FFAR1TSHR | |
| SCHEMBL3813886 | 1.00 | CYP1A2 (0.67) | CYP1A2LTA4HFFAR4FFAR1TSHR | |
| SCHEMBL5710453 | 1.00 | CYP1A2 (0.67) | CYP1A2LTA4HFFAR4FFAR1TSHR | |
| SCHEMBL3811423 | 1.00 | CYP1A2 (0.67) | CYP1A2LTA4HFFAR4FFAR1TSHR | |
| SCHEMBL2763157 | 1.00 | CYP1A2 (0.67) | CYP1A2LTA4HFFAR4FFAR1TSHR | |
| SCHEMBL3818540 | 1.00 | CYP1A2 (0.67) | CYP1A2LTA4HFFAR4FFAR1TSHR | |
| SCHEMBL3816098 | 1.00 | CYP1A2 (0.67) | CYP1A2LTA4HFFAR4FFAR1TSHR | |
| SCHEMBL2835395 | 1.00 | CYP1A2 (0.67) | CYP1A2LTA4HFFAR4FFAR1TSHR | |
| SCHEMBL3812601 | 1.00 | CYP1A2 (0.67) | CYP1A2LTA4HFFAR4FFAR1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 694 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2418030-B1 | CURING AGENT COMPOSITION | KAO CORP (JP) | 2019-09-25 | — | — | EP | claimed |
| EP-2427435-B1 | SUBSTITUTED PHENYLUREAS AND PHENYLAMIDES AS VANILLOID RECEPTOR LIGANDS | MEDIFRON DBT INC (KR) | 2017-06-14 | — | — | EP | claimed |
| CN-101622256-B | Spirocyclic cyclohexane derivatives | GRUENENTHAL CHEMIE | 2015-07-22 | — | — | CN | claimed |
| US-7960404-B2 | Spirocyclic cyclohexane compounds | GRUENENTHAL GMBH (DE) | 2011-06-14 | — | — | US | claimed |
| US-20100048553-A1 | Spirocyclic Cyclohexane Compounds | GRUENENTHAL GMBH (DE) | 2010-02-25 | — | — | US | claimed |
| EP-0986619-B1 | LOW VOLATILE ORGANIC SOLVENT BASED ADHESIVE | NOVEON IP HOLDINGS CORP (US) | 2004-09-01 | — | — | EP | claimed |
| EP-0556948-A2 | Liquid electrolytes and electrolytic capacitors using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1993-08-25 | — | — | EP | claimed |
| US-12473405-B2 | Polyorganosiloxane, polyorganosiloxane composition, cured product, polyorganosiloxane-containing electrolytic solution for electrolytic capacitor, and electrolytic capacitor using same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2025-11-18 | — | — | US | disclosed |
| EP-4638441-A1 | GLYCINE DERIVATIVES WITH P2X4 RECEPTOR-BLOCKING ACTIVITY AS DIAGNOSTICS AND FOR THE TREATMENT OF PAIN, INFLAMMATION, CANCER, AND OTHER P2X4 RECEPTOR-RELATED DISEASES | Rheinische Friedrich-Wilhelms-Universität Bonn (DE) | 2025-10-29 | — | — | EP | disclosed |
| EP-3386508-B1 | CPAP-TUBULIN MODULE | UNIV KOELN (DE) | 2025-04-16 | — | — | EP | disclosed |
| WO-2024133499-A1 | GLYCINE DERIVATIVES WITH P2X4 RECEPTOR-BLOCKING ACTIVITY AS DIAGNOSTICS AND FOR THE TREATMENT OF PAIN, INFLAMMATION, CANCER, AND OTHER P2X4 RECEPTOR-RELATED DISEASES | RHEINISCHE-FRIEDRICH-WILHELMS-UNIVERSITÄT BONN (DE) | 2024-06-27 | — | — | WO | disclosed |
| WO-2023202052-A1 | METHOD FOR PREPARING 10-OXO-NONADECANEDIOIC ACID | 深圳深信生物科技有限公司 | 2023-10-26 | — | — | WO | disclosed |
| US-20230250237-A1 | POLYORGANOSILOXANE, POLYORGANOSILOXANE COMPOSITION, CURED PRODUCT, POLYORGANOSILOXANE-CONTAINING ELECTROLYTIC SOLUTION FOR ELECTROLYTIC CAPACITOR, AND ELECTROLYTIC CAPACITOR USING SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-08-10 | — | — | US | disclosed |
| WO-1999015528-A1 | ACIDIC ADDITION SALTS OF MORPHINE ALKALOIDS AND THE APPLICATION THEREOF | LTS LOHMANN THERAPIE-SYSTEME AG (DE) | 1999-04-01 | — | — | WO | disclosed |
| CN-1200721-A | Process for preparing alkyl carboxylates | TORAY INDUSTRIES (JP) | 1998-12-02 | — | — | CN | disclosed |
| EP-0854131-A1 | PROCESS FOR THE PREPARATION OF ALKYL CARBOXYLATES | TORAY INDUSTRIES, INC. (JP) | 1998-07-22 | — | — | EP | disclosed |
| US-5567411-A | ADMINISTERING TO A WARM-BLOODED ANIMAL TO OBTAIN A MAGNETIC RESONANCE IMAGE OF SUBJECT | STATE OF OREGON ACTING BY AND THROUGH THE STATE BOARD OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF OREGON (US) | 1996-10-22 | — | — | US | disclosed |
| EP-0556948-A2 | Liquid electrolytes and electrolytic capacitors using the same | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1993-08-25 | — | — | EP | disclosed |
| US-4281104-A | CONTAINING UNITS OF NEOPENTYL GLYCOL HYDROXYPIVALATE, AND USED TO BIND METAL OXIDE PIGMENTS TO MAGNETIC TAPE SUBSTRATES | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1981-07-28 | — | — | US | disclosed |
| US-4201859-A | ETHYLENE GLYCOL, TEREPHTHALIC ACID, PHTHALIC ACID, AND AN ALIPHATIC DICARBOXYLIC ACIDF SOLUBILITY, SHELF LIFE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1980-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048553-A1 | Spirocyclic Cyclohexane Compounds | PKD2, PKD1, RYR1 | CYP1A2 38/4885LTA4H 2776/4885FFAR4 2204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.